S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities

Sage Therapeutics (SAGE) News Today

$13.04
+0.46 (+3.66%)
(As of 04/18/2024 ET)
SourceHeadline
marketbeat.com logoQ1 2024 Earnings Estimate for Sage Therapeutics, Inc. (NASDAQ:SAGE) Issued By Wedbush
marketbeat.com - April 19 at 8:17 AM
MarketBeat logoSage Therapeutics (NASDAQ:SAGE) Stock Rating Reaffirmed by HC Wainwright
americanbankingnews.com - April 19 at 2:31 AM
MarketBeat logoSage Therapeutics (NASDAQ:SAGE) Rating Reiterated by Wedbush
americanbankingnews.com - April 19 at 2:31 AM
MarketBeat logoSage Therapeutics (NASDAQ:SAGE) Cut to Underperform at Bank of America
americanbankingnews.com - April 19 at 1:44 AM
marketbeat.com logoSage Therapeutics (NASDAQ:SAGE) Trading Up 6.2%
marketbeat.com - April 18 at 4:33 PM
marketbeat.com logoScotiabank Lowers Sage Therapeutics (NASDAQ:SAGE) Price Target to $19.00
marketbeat.com - April 18 at 10:28 AM
msn.com logoB of A Securities Downgrades Sage Therapeutics (SAGE)
msn.com - April 18 at 10:27 AM
markets.businessinsider.com logoIn-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics
markets.businessinsider.com - April 18 at 10:27 AM
marketbeat.com logoSage Therapeutics (NASDAQ:SAGE) Given Hold Rating at Needham & Company LLC
marketbeat.com - April 18 at 8:23 AM
MarketBeat logoSage Therapeutics (SAGE) Scheduled to Post Earnings on Thursday
americanbankingnews.com - April 18 at 2:48 AM
msn.com logoSage Therapeutics stock plunges 20 percent after Parkinson’s drug fails study
msn.com - April 17 at 6:40 PM
marketbeat.com logoWedbush Reiterates Neutral Rating for Sage Therapeutics (NASDAQ:SAGE)
marketbeat.com - April 17 at 3:51 PM
benzinga.com logoNeurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data
benzinga.com - April 17 at 1:38 PM
msn.com logoBofA downgrades Sage to underperform, cites failed Parkinson's study
msn.com - April 17 at 1:38 PM
markets.businessinsider.com logoNasdaq Down Over 1%; Sage Therapeutics Shares Plunge
markets.businessinsider.com - April 17 at 1:38 PM
finance.yahoo.com logoSage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark
finance.yahoo.com - April 17 at 1:38 PM
marketbeat.com logoSage Therapeutics (NASDAQ:SAGE) Shares Gap Down to $15.63
marketbeat.com - April 17 at 11:37 AM
investors.com logoSage Therapeutics Hammered After Parkinson's Drug Misses The Mark
investors.com - April 17 at 8:46 AM
marketwatch.com logoSage Therapeutics Stops Further Development of Dalzanemdor in Parkinson's Disease
marketwatch.com - April 17 at 8:38 AM
marketwatch.com logoSage Therapeutics Shares Sink Premarket After Setback in Development of Dalzanemdor
marketwatch.com - April 17 at 8:38 AM
markets.businessinsider.com logoSage Therapeutics' Dalzanemdor Phase 2 Study Fails To Meet Primary Endpoint
markets.businessinsider.com - April 17 at 8:38 AM
msn.com logoSage drops after mid-stage setback for Parkinson’s disease candidate
msn.com - April 17 at 8:38 AM
reuters.com logoSage Therapeutics scraps Parkinson's drug development after treatment fails mid-stage study
reuters.com - April 17 at 8:38 AM
finance.yahoo.com logoSage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
finance.yahoo.com - April 17 at 8:38 AM
marketbeat.com logoSage Therapeutics (NASDAQ:SAGE) Hits New 1-Year Low at $15.06
marketbeat.com - April 16 at 2:58 PM
MarketBeat logoLeerink Partnrs Research Analysts Boost Earnings Estimates for Sage Therapeutics, Inc. (NASDAQ:SAGE)
americanbankingnews.com - April 13 at 1:28 AM
marketbeat.com logoQ1 2024 EPS Estimates for Sage Therapeutics, Inc. (NASDAQ:SAGE) Raised by Analyst
marketbeat.com - April 12 at 6:08 AM
MarketBeat logoSage Therapeutics (NASDAQ:SAGE) Hits New 1-Year Low at $15.88
americanbankingnews.com - April 12 at 4:06 AM
MarketBeat logoSage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Recommendation of "Hold" by Brokerages
americanbankingnews.com - April 12 at 2:48 AM
businesswire.com logoSage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
businesswire.com - April 11 at 6:30 AM
marketbeat.com logoVanguard Group Inc. Has $107.18 Million Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - April 5 at 4:06 AM
marketbeat.com logoSage Therapeutics (NASDAQ:SAGE) Hits New 12-Month Low at $16.48
marketbeat.com - April 4 at 6:52 PM
msn.com logoZelda: Tears of the Kingdom T-shirts are coming to Uniqlo in late April
msn.com - April 3 at 9:25 PM
finance.yahoo.com logoWe're Keeping An Eye On Sage Therapeutics' (NASDAQ:SAGE) Cash Burn Rate
finance.yahoo.com - March 28 at 11:11 AM
markets.businessinsider.com logoDemystifying Sage Therapeutics: Insights From 5 Analyst Reviews
markets.businessinsider.com - March 26 at 2:07 PM
marketbeat.com logoSage Therapeutics (NASDAQ:SAGE) Shares Gap Up Following Analyst Upgrade
marketbeat.com - March 26 at 12:42 PM
marketbeat.com logoSage Therapeutics (NASDAQ:SAGE) Price Target Increased to $29.00 by Analysts at JPMorgan Chase & Co.
marketbeat.com - March 26 at 8:47 AM
marketbeat.com logoSage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Teachers Retirement System of The State of Kentucky
marketbeat.com - March 22 at 4:35 AM
msn.com logoThis company is treating postpartum depression in 2 weeks with a daily pill
msn.com - March 20 at 7:20 PM
marketbeat.com logoSage Therapeutics, Inc. (NASDAQ:SAGE) Given Average Recommendation of "Hold" by Analysts
marketbeat.com - March 18 at 2:56 AM
marketbeat.com logoSage Therapeutics, Inc. (NASDAQ:SAGE) Shares Bought by Citigroup Inc.
marketbeat.com - March 17 at 5:10 AM
marketbeat.com logoHudson Bay Capital Management LP Raises Stock Position in Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - March 15 at 6:57 AM
marketbeat.com logoJacobs Levy Equity Management Inc. Acquires Shares of 391,231 Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - March 13 at 6:56 AM
barrons.com logoSage Therapeutics Inc.
barrons.com - March 11 at 4:25 AM
marketbeat.com logoSchonfeld Strategic Advisors LLC Raises Position in Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - March 7 at 6:40 AM
marketbeat.com logoRTW Investments LP Purchases New Position in Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - March 6 at 11:00 AM
marketbeat.com logoSage Therapeutics, Inc. (NASDAQ:SAGE) Holdings Lifted by Palo Alto Investors LP
marketbeat.com - March 1 at 10:27 AM
markets.businessinsider.com logoPeeling Back The Layers: Exploring Sage Therapeutics Through Analyst Insights
markets.businessinsider.com - February 28 at 5:41 PM
marketbeat.com logoAlgert Global LLC Makes New $1.17 Million Investment in Sage Therapeutics, Inc. (NASDAQ:SAGE)
marketbeat.com - February 28 at 6:37 AM
businesswire.com logoSage Therapeutics to Present at Upcoming March Investor Conferences
businesswire.com - February 28 at 6:30 AM
Get Sage Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAGE and its competitors with MarketBeat's FREE daily newsletter.

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

SAGE Media Mentions By Week

SAGE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SAGE
News Sentiment

-0.18

0.53

Average
Medical
News Sentiment

SAGE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SAGE Articles
This Week

36

5

SAGE Articles
Average Week

Get Sage Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAGE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:SAGE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners